In models of non-alcoholic steatohepatitis (NASH), caffeine ameliorated hepatic inflammation by downregulating TLR4/MAPK/NF-κB signaling and suppressing NLRP3 inflammasome activation (94). The gene discussed is NLRP3; the disease is metabolic dysfunction-associated steatohepatitis.